End-of-Life Care: Palliative Care, Hospice, Advance Directives, and Symptom Management

Introduction

End-of-life care focuses on maximizing quality of life for individuals with serious, progressive, or terminal illness. It encompasses physical symptom management, psychosocial and spiritual support, and assistance with medical decision-making. Early integration of palliative care improves outcomes, quality of life, and family satisfaction while potentially extending survival.

Palliative Care Versus Hospice Care

Aspect	Palliative Care	Hospice Care
Timing	Any stage of serious illness, concurrent with curative treatment	Last 6 months of life, after curative treatment stopped
Prognosis requirement	None	Physician certifies life expectancy of 6 months or less
Curative treatment	Can continue simultaneously	Must forego curative treatment
Setting	Hospital, clinic, home, nursing home	Home, hospice facility, nursing home
Team	MD, RN, social worker, chaplain, specialist	Same core team, more intensive home support
Medicare coverage	Part B (physician), Part D (meds)	Medicare Hospice Benefit (comprehensive)
Goal	Symptom management, quality of life, support	Comfort-focused care at end of life
Duration	Months to years	Days to months (average 70 days)

Advance Care Planning

Components of Advance Care Planning

Component	Description
Values exploration	What matters most to the person (comfort, independence, family burden)
Goals of care discussion	Priorities: quantity vs. quality of life, acceptable trade-offs
Advance directive	Legal document stating preferences
Healthcare power of attorney	Designated decision-maker
POLST/MOLST	Medical orders for life-sustaining treatment (actionable in real time)
Living will	Specific treatment preferences (ventilator, feeding tube, CPR)
Five Wishes	Comprehensive advance directive combining legal, medical, personal, spiritual

Key Steps in Advance Care Planning

Step	Action
1	Identify your values and preferences
2	Choose a healthcare proxy who understands your values
3	Discuss your wishes with proxy and family
4	Complete advance directive documents
5	Provide copies to proxy, doctor, hospital, family
6	Review and update periodically (or after major health changes)

Goals of Care Conversations

Element	Description	Example Question
Understanding current status	Assess patient’s understanding of illness	“What is your understanding of where things are with your illness?”
Information sharing	Provide prognosis and options	“Would you like me to share what I think the next months may look like?”
Explore values	What matters most	“What gives you strength? What are your worries?”
Recommend a direction	Physician recommendation based on values	“Given what you’ve said about being at home, I recommend we focus on comfort and support rather than hospitalization.”
Affirm commitment	Reassure about non-abandonment	“We will be with you every step of the way regardless of decisions.”

Symptom Management at End of Life

Pain

Type	First-Line	Second-Line	Adjuvants
Nociceptive (somatic)	Acetaminophen, NSAIDs	Opioids	Muscle relaxants
Nociceptive (visceral)	Opioids	Opioid rotation	Antispasmodics
Neuropathic	Gabapentin, pregabalin, TCAs	SNRIs, topical lidocaine	Opioids as second-line
Bone pain	NSAIDs, opioids	Radiation, bisphosphonates	Corticosteroids
Breakthrough pain	Short-acting opioids	Buccal or intranasal fentanyl	Optimize around-the-clock dosing

WHO Analgesic Ladder

Step	Medications	Indication
1	Non-opioids (acetaminophen, NSAIDs)	Mild pain
2	Weak opioids (codeine, tramadol) +/- non-opioids	Mild to moderate pain
3	Strong opioids (morphine, hydromorphone, fentanyl) +/- non-opioids	Moderate to severe pain

Dyspnea (Shortness of Breath)

Intervention	Dose/Regimen	Notes
Opioids	Morphine 2.5-5 mg PO q4h or 1-2 mg IV q1h PRN	First-line pharmacologic treatment
Oxygen	2-4 L/min if hypoxic	No benefit for non-hypoxic dyspnea
Fan or open window	Cool air on face	Non-pharmacologic, effective
Positioning	Upright, elevated head of bed	Optimizes diaphragm mechanics
Anxiolytics	Lorazepam 0.5-1 mg PO/SL q6h PRN	For anxiety component
Bronchodilators	Albuterol MDI 2 puffs q4-6h PRN	If COPD/reactive airway disease

Nausea and Vomiting

Cause	Medication	Dose
Opioid-induced	Metoclopramide 10 mg PO/IV q6h	Promotility agent
Chemotherapy	Ondansetron 8 mg PO/IV q8h	5-HT3 antagonist
GI obstruction	Dexamethasone 4-8 mg IV daily	Anti-inflammatory
Increased ICP	Dexamethasone 4-8 mg IV q6h	Vasogenic edema reduction
Metabolic (e.g., hypercalcemia)	Haloperidol 0.5-2 mg PO/SL/IV q6h	Antidopaminergic

Terminal Secretions (Death Rattle)

Intervention	Regimen	Notes
Scopolamine	1-3 patches transdermal q72h	First-line
Glycopyrrolate	0.2-0.4 mg IV/SC q4-6h	Less CNS side effects
Atropine 1%	1-2 drops SL q2-4h PRN	Short-acting
Positioning	Turn patient to side	Postural drainage
Suctioning	Gentle oral suction if needed	Avoid deep suctioning (can cause discomfort)

The Dying Process: What to Expect

Phase	Signs	Timing	Comfort Measures
Weeks to months	Decreased appetite, increased sleep, social withdrawal	1-3 months before death	Accept reduced intake, encourage favorite foods
Days	Decreased consciousness, changes in breathing, skin mottling	1-2 weeks	Mouth care, gentle turning
Active dying	Irregular breathing (Cheyne-Stokes), terminal secretions, agitation, changes in circulation	Last 24-72 hours	Medication for secretions, agitation; family presence
Hours	Agonal breathing, decreased BP, cool extremities, loss of reflexes	Last hours	Reassurance, comfort positioning
Moment of death	No breathing, no pulse, pupils fixed	Brief moment	Allow family time, pronouncement

Grief and Bereavement

Types of Grief

Type	Description	Duration
Normal grief	Sadness, crying, social withdrawal, preoccupation with deceased	6-12 months, varies widely
Anticipatory grief	Grief experienced before death during terminal illness	Weeks to months before death
Complicated grief	Prolonged, intense grief with functional impairment	>12 months, requires treatment
Disenfranchised grief	Grief not socially recognized (ex-spouse, non-traditional relationship)	Variable
Traumatic grief	Grief with PTSD symptoms (sudden, violent death)	Months to years

Interventions for Grief

Intervention	Description	Evidence
Supportive counseling	Active listening, validation, normalization	Effective for normal grief
Complicated grief therapy	Targeted therapy for prolonged grief disorder	Effective
Bereavement support groups	Peer support, shared experience	Reduces isolation
Antidepressants	For major depression (not for grief alone)	If depression criteria met
Mindfulness	Present-focused acceptance	Reduces distress

Conclusion

End-of-life care is an essential component of comprehensive healthcare. Early advance care planning, skilled symptom management, and psychosocial support can dramatically improve the dying experience for patients and families. Healthcare providers, families, and the broader community share responsibility for ensuring dignity, comfort, and support during this universal human experience.